Research

Cellular

Observational data suggest GLP-1 RAs improve walking distance in peripheral artery disease.

GLP-1 RAs may enhance mobility in patients with peripheral artery disease.

GoodSupportsmedium confidence
Observational data and post hoc analyses report fewer adverse limb events and improved walking distance in peripheral artery disease.
Kanwardeep Singh et al. · Cardiology in Review · 2025

Why this rating

Based on observational data and post hoc analyses.

Source

Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic Disease

Kanwardeep Singh et al. · Cardiology in Review · 2025

DOI 10.1097/crd.0000000000001045

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →